Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
Provided By GlobeNewswire
Last update: Mar 5, 2025
RADNOR, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Adrian McKemey, Ph.D. as President of Drug Development Solutions, effective March 3rd, 2025. In this role, McKemey will lead Certara's global team of drug development scientists.
Read more at globenewswire.com
